Market Closed -
OTC Markets
07:43:24 24/06/2024 pm IST
|
5-day change
|
1st Jan Change
|
9
USD
|
+2.27%
|
|
+2.27%
|
+20.00%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,165
|
5,534
|
10,558
|
5,889
|
4,873
|
6,065
|
-
|
-
|
Enterprise Value (EV)
1 |
2,251
|
5,618
|
10,490
|
5,858
|
4,575
|
6,000
|
6,140
|
6,369
|
P/E ratio
|
7.92
x
|
14.2
x
|
17.7
x
|
58.3
x
|
43.3
x
|
55.1
x
|
38.3
x
|
32.5
x
|
Yield
|
9.69%
|
4.11%
|
2.44%
|
0.94%
|
1.23%
|
1.06%
|
1.15%
|
1.38%
|
Capitalization / Revenue
|
6.9
x
|
13.8
x
|
21
x
|
11.1
x
|
8.44
x
|
9.78
x
|
7.48
x
|
6.02
x
|
EV / Revenue
|
7.17
x
|
14
x
|
20.8
x
|
11
x
|
7.92
x
|
9.68
x
|
7.57
x
|
6.32
x
|
EV / EBITDA
|
25.8
x
|
45.8
x
|
66.6
x
|
36.5
x
|
27.4
x
|
33.2
x
|
25.4
x
|
20.6
x
|
EV / FCF
|
66.8
x
|
122
x
|
-544
x
|
-128
x
|
-311
x
|
359
x
|
-40.9
x
|
-39.3
x
|
FCF Yield
|
1.5%
|
0.82%
|
-0.18%
|
-0.78%
|
-0.32%
|
0.28%
|
-2.44%
|
-2.55%
|
Price to Book
|
0.96
x
|
2.33
x
|
1.81
x
|
5.03
x
|
3.68
x
|
4.42
x
|
4.22
x
|
3.87
x
|
Nbr of stocks (in thousands)
|
69,926
|
69,959
|
73,732
|
73,750
|
74,971
|
74,974
|
-
|
-
|
Reference price
2 |
30.96
|
79.10
|
143.2
|
79.85
|
65.00
|
80.90
|
80.90
|
80.90
|
Announcement Date
|
13/03/20
|
12/03/21
|
18/03/22
|
07/03/23
|
07/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
313.7
|
402
|
503.2
|
531.7
|
577.3
|
619.9
|
811
|
1,008
|
EBITDA
1 |
87.2
|
122.6
|
157.4
|
160.5
|
166.7
|
180.7
|
241.7
|
309.7
|
EBIT
1 |
62.36
|
96.7
|
128.9
|
127.2
|
129.4
|
130.3
|
176.9
|
234
|
Operating Margin
|
19.88%
|
24.05%
|
25.62%
|
23.93%
|
22.41%
|
21.02%
|
21.81%
|
23.22%
|
Earnings before Tax (EBT)
1 |
60.37
|
90.96
|
131.4
|
112.1
|
124.2
|
123.4
|
185.7
|
200.8
|
Net income
1 |
54.16
|
78.1
|
114.7
|
100.7
|
111.9
|
104.9
|
160.1
|
170.7
|
Net margin
|
17.27%
|
19.43%
|
22.79%
|
18.93%
|
19.38%
|
16.92%
|
19.74%
|
16.94%
|
EPS
2 |
3.910
|
5.580
|
8.090
|
1.370
|
1.500
|
1.467
|
2.114
|
2.487
|
Free Cash Flow
1 |
33.68
|
45.94
|
-19.27
|
-45.81
|
-14.7
|
16.7
|
-150
|
-162.1
|
FCF margin
|
10.74%
|
11.43%
|
-3.83%
|
-8.62%
|
-2.55%
|
2.69%
|
-18.49%
|
-16.08%
|
FCF Conversion (EBITDA)
|
38.62%
|
37.47%
|
-
|
-
|
-
|
9.24%
|
-
|
-
|
FCF Conversion (Net income)
|
62.18%
|
58.83%
|
-
|
-
|
-
|
15.92%
|
-
|
-
|
Dividend per Share
2 |
3.000
|
3.250
|
3.500
|
0.7500
|
0.8000
|
0.8600
|
0.9333
|
1.117
|
Announcement Date
|
13/03/20
|
12/03/21
|
18/03/22
|
07/03/23
|
07/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
---|
Net sales
1 |
179.2
|
177.1
|
224.9
|
239.1
|
264.1
|
234.9
|
296.9
|
239.9
|
337.5
|
EBITDA
1 |
50.7
|
53
|
69.6
|
75.5
|
81.9
|
67.3
|
93.2
|
52.5
|
114.2
|
EBIT
1 |
37.94
|
40.26
|
56.44
|
61.95
|
66.95
|
51.56
|
75.66
|
34.82
|
94.56
|
Operating Margin
|
21.17%
|
22.73%
|
25.1%
|
25.9%
|
25.35%
|
21.95%
|
25.49%
|
14.51%
|
28.02%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
40.36
|
71.72
|
36.92
|
-
|
Net income
1 |
-
|
32.83
|
45.27
|
53.12
|
61.58
|
36.61
|
64.07
|
34.45
|
77.41
|
Net margin
|
-
|
18.53%
|
20.13%
|
22.21%
|
23.32%
|
15.59%
|
21.58%
|
14.36%
|
22.94%
|
EPS
2 |
-
|
2.350
|
3.230
|
3.800
|
4.290
|
0.5000
|
0.8700
|
0.4600
|
1.040
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
13/03/20
|
21/08/20
|
12/03/21
|
27/08/21
|
18/03/22
|
25/08/22
|
07/03/23
|
27/07/23
|
07/03/24
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
85.7
|
84.1
|
-
|
-
|
-
|
-
|
74.8
|
303
|
Net Cash position
1 |
-
|
-
|
68.3
|
30.8
|
299
|
64.9
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.9825
x
|
0.6856
x
|
-
|
-
|
-
|
-
|
0.3096
x
|
0.9789
x
|
Free Cash Flow
1 |
33.7
|
45.9
|
-19.3
|
-45.8
|
-14.7
|
16.7
|
-150
|
-162
|
ROE (net income / shareholders' equity)
|
13%
|
16.9%
|
14.4%
|
8.8%
|
9%
|
8.36%
|
10.8%
|
12.9%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
32.40
|
34.00
|
79.10
|
15.90
|
17.70
|
18.30
|
19.20
|
20.90
|
Cash Flow per Share
2 |
4.640
|
8.220
|
6.890
|
1.260
|
3.350
|
1.860
|
2.230
|
3.040
|
Capex
1 |
28.8
|
65.5
|
115
|
138
|
265
|
308
|
261
|
285
|
Capex / Sales
|
9.18%
|
16.3%
|
22.77%
|
26.04%
|
45.83%
|
49.71%
|
32.2%
|
28.31%
|
Announcement Date
|
13/03/20
|
12/03/21
|
18/03/22
|
07/03/23
|
07/03/24
|
-
|
-
|
-
|
Mean consensus UNDERPERFORM Last Close Price
80.9
CHF Average target price
70.8
CHF Spread / Average Target -12.48% Consensus |
1st Jan change
|
Capi.
|
---|
| +23.13% | 5.27TCr | | +37.49% | 3.9TCr | | -8.73% | 3.85TCr | | +28.09% | 3.04TCr | | -12.26% | 2.64TCr | | +10.57% | 2.61TCr | | +45.05% | 1.42TCr | | +32.23% | 1.26TCr | | -6.56% | 1.15TCr |
Other Biotechnology & Medical Research
|